We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$122M
RCM
2
RA Capital Management
Massachusetts
$53.8M
O
3
OrbiMed
New York
$51M
NI
4
Nextech Invest
Switzerland
$37.9M
VVA
5
Vida Ventures Advisors
Massachusetts
$34.6M
BlackRock
6
BlackRock
New York
$29M +$2.27M +244,320 +12%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$27.7M +$6.97M +749,012 +52%
BC
8
Boxer Capital
California
$23.3M
Viking Global Investors
9
Viking Global Investors
Connecticut
$23M
LCM
10
Lynx1 Capital Management
Puerto Rico
$21.1M +$9.14M +982,169 +142%
Citadel Advisors
11
Citadel Advisors
Florida
$14.2M -$52.7K -5,665 -0.5%
Vanguard Group
12
Vanguard Group
Pennsylvania
$12.6M -$4.28M -459,557 -32%
FCMV
13
Foresite Capital Management V
California
$11M
NHAS
14
Novo Holdings A/S
Denmark
$10.3M +$1.78M +191,471 +31%
RSCM
15
Rock Springs Capital Management
Maryland
$7.8M +$2.55M +274,238 +80%
HMC
16
Harvard Management Company
Massachusetts
$6.28M
State Street
17
State Street
Massachusetts
$5.7M +$271K +29,124 +7%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$5.18M +$422K +45,381 +12%
American Century Companies
19
American Century Companies
Missouri
$4.04M +$3.98K +428 +0.1%
Federated Hermes
20
Federated Hermes
Pennsylvania
$3.88M
FCOMV
21
Foresite Capital Opportunity Management V
California
$3.68M
WP
22
Woodline Partners
California
$3.28M
DM
23
Deerfield Management
New York
$3.15M -$6.85M -735,568 -75%
Northern Trust
24
Northern Trust
Illinois
$2.85M +$165K +17,769 +9%
DCM
25
DAFNA Capital Management
California
$2.83M +$710K +76,300 +52%